| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/16/2010 | WO2010103837A1 Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses |
| 09/16/2010 | WO2010102788A1 Prodrugs |
| 09/16/2010 | US20100234564 Methods and intermediates for chemical synthesis of polypeptides and proteins |
| 09/16/2010 | US20100234563 Methods for Preparing Internally Constrained Peptides and Peptidomimetics |
| 09/16/2010 | US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 09/16/2010 | US20100234289 Integrin binding rgd-lipopeptides with gene transfer activities |
| 09/16/2010 | US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233676 High affinity fluorochrome binding peptides |
| 09/16/2010 | US20100233161 Novel multifunctional compounds for pharmaceutical purposes |
| 09/16/2010 | US20100233146 Coatings and Surface Treatments Having Active Enzymes and Peptides |
| 09/16/2010 | CA2754846A1 Prostate-specific antigen cleavable prodrugs |
| 09/15/2010 | EP2228388A1 Protected Arg-Glu-Arg polypeptides and uses thereof |
| 09/15/2010 | EP2228387A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 09/15/2010 | EP2228381A2 Alpha-MSH antagonist dipeptide conjugates |
| 09/15/2010 | EP2228068A1 Therapeutic agent for cerebral ischemic injury |
| 09/15/2010 | EP1450857B1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/15/2010 | CN101835484A Antibody-mediated disruption of quorum sensing in bacteria |
| 09/15/2010 | CN101830967A Oligopeptide with angiotensin transferase inhibiting activity and preparation method thereof |
| 09/15/2010 | CN101830937A Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module |
| 09/14/2010 | US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy |
| 09/14/2010 | US7795386 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 09/14/2010 | US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents |
| 09/14/2010 | US7795379 Expression vectors, eukaryotic and prokaryotic cell lines; cancer vaccines |
| 09/14/2010 | US7795378 Erectile dysfunction |
| 09/14/2010 | US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases |
| 09/14/2010 | US7795222 administering peptide comprising claimed amino acid sequence; insulin-like growth factor; therapy for vision defects, skin disorders; wound healing agents; antiulcer agents |
| 09/14/2010 | US7795203 topically applying an aqueous ophthalmic composition comprising N-acetylcarnosine, a N-acetylcarnosine derivative and a cellulose compound which increases intraocular absorption of N-acetylcarnosine; a hydrophilic hydrogel contact lens and an ocular polymer insert for topical application |
| 09/14/2010 | US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains |
| 09/14/2010 | CA2277911C Compounds and their combinations for the treatment of influenza infection |
| 09/09/2010 | US20100228004 Templates for nucleation and propagation of peptide secondary structure |
| 09/09/2010 | US20100227824 Pharmaceutical peptides for the treatment of inflammatory diseases |
| 09/09/2010 | US20100227343 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/08/2010 | EP2225261A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 09/08/2010 | EP2224920A1 Process for making macrocyclic oximyl hepatitis c protease inhibitors |
| 09/08/2010 | EP2224801A1 Macrocyclic oximyl hepatitis c serine protease inhibitors |
| 09/08/2010 | EP1429797B1 Diagnosis and treatment of malignant neoplasms |
| 09/08/2010 | EP1377304B1 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 09/08/2010 | CN1908009B Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 09/08/2010 | CN101824072A Short peptide for inhibiting growth of solid tumor and leukemia cancer cells and application thereof |
| 09/08/2010 | CN101824071A Antioxidant peptide from collagen and application thereof |
| 09/08/2010 | CN101134774B Combined chemical modified endomorphin-1 and method for preparing same |
| 09/07/2010 | US7790861 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer in mammals |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790708 Prodrugs of GABA analogs, compositions and uses thereof |
| 09/07/2010 | US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents |
| 09/07/2010 | CA2450871C Assay for identifying inhibitors of hiv rt dimerization |
| 09/07/2010 | CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
| 09/02/2010 | US20100222608 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors |
| 09/02/2010 | US20100222549 Dechalcogenative methods for the preparation of allylic sulfides |
| 09/02/2010 | US20100222548 Method for producing condensation products from n-substituted glycine derivatives(peptoids) by sequential ugi-multicomponent reactions |
| 09/02/2010 | US20100221839 Metal Abstraction Peptide (MAP) Tag and Associated Methods |
| 09/02/2010 | US20100221261 Iap bir domain binding compounds |
| 09/01/2010 | EP2222325A2 Compositions for reducing oxidative stress and uses thereof |
| 09/01/2010 | EP2222324A2 Boceprevir derivatives for the treatment of hcv infections |
| 09/01/2010 | EP1028942B1 Dipeptide nitriles |
| 09/01/2010 | CN101817870A Thyrotropin-releasing hormone and preparation method of pharmaceutically usable salt thereof |
| 09/01/2010 | CN101062938B Preparation method of N(2)-L-alanyl-L-glutamine |
| 08/31/2010 | US7786321 Compounds of the N-acylamino amide family compositions comprising them and uses thereof |
| 08/31/2010 | US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody |
| 08/31/2010 | US7785824 Hydrolysed casein product comprising tripeptides IPP and/or VPP |
| 08/31/2010 | US7785577 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 08/26/2010 | WO2010095953A1 Process for purifying lipopeptides |
| 08/26/2010 | WO2010095365A1 Evaluation peptide for use in quantification of protein using mass spectrometer, artificial standard protein, and method for quantifying protein |
| 08/26/2010 | WO2010075983A8 Process for the production of bivalirudin |
| 08/26/2010 | US20100216824 Anti-cancer cyclopenta [G]quinazonline compounds |
| 08/26/2010 | US20100216725 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 08/26/2010 | US20100216701 Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes |
| 08/26/2010 | US20100216182 Cyanine-Based Probe\Tag-Peptide Pair Fluorescence Protein Imaging and Fluorescence Protein Imaging Methods |
| 08/26/2010 | US20100216180 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry |
| 08/26/2010 | US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm |
| 08/26/2010 | US20100215649 Antibodies for norovirus |
| 08/26/2010 | CA2748932A1 Process for purifying lipopeptides |
| 08/25/2010 | EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 08/25/2010 | CN101812117A Method for extracting glutathione |
| 08/25/2010 | CN101810847A Inflammation-inhibiting compounds |
| 08/25/2010 | CN101235078B Method for generating amido bond |
| 08/24/2010 | US7780960 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography |
| 08/24/2010 | CA2551182C Novel kappa receptor selective opioid peptides |
| 08/24/2010 | CA2512442C Method for producing .alpha.-l-aspartyl-l-phenylalanine-.beta.-ester and method for producing .alpha.-l-aspartyl-l-phenylalanine-.alpha.-methyl ester |
| 08/24/2010 | CA2474031C Heterocyclic tripeptides as hepatitis c inhibitors |
| 08/19/2010 | WO2010093284A1 Dipeptide mimetics of ngf and bdnf neurotrophins |
| 08/19/2010 | WO2010091893A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 08/19/2010 | WO2010046900A3 Rgd-containing peptidomimetics and uses thereof |
| 08/19/2010 | US20100210817 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2010 | US20100210603 Novel sulfonamide inhibitors of aspartyl protease |
| 08/19/2010 | US20100210568 Thyrotropin releasing hormone for therapeutic applications |
| 08/19/2010 | US20100210567 Use of a tuftsin as a therapeutic agent |
| 08/19/2010 | US20100210564 Drug or food containing a peptide |
| 08/19/2010 | US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments |
| 08/19/2010 | CA2751436A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 08/18/2010 | CN101809032A Method for selectively modifying a protein |
| 08/18/2010 | CN101809028A Novel lipid peptide and hydrogel |
| 08/18/2010 | CN101809027A selective inhibitors of neurotensin degrading enzymes |
| 08/18/2010 | CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/17/2010 | US7777069 Prodrugs of carbamate inhibitors of IMPDH |
| 08/17/2010 | US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein |
| 08/17/2010 | US7777004 Polypeptides comprising Fas activation and NKG2D-ligand domains |
| 08/17/2010 | US7776828 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 08/17/2010 | US7776814 with cyclodextrins, polyoxyethylene glycol; anticancer agents |